When investing a meaningful sum like $50,000, my goal is not to be clever. It is to build a portfolio that balances quality, growth, and resilience, while keeping the number of moving parts manageable.
I am not trying to predict short-term market moves. Instead, I want exposure to businesses and assets that I would be comfortable holding through volatility, knowing that time and fundamentals can do the heavy lifting.
If I were investing $50,000 across the ASX right now, this is how I would allocate it.
$15,000 in Wesfarmers Ltd (ASX: WES)
Wesfarmers is not cheap, but I am willing to pay a premium for quality when the business has a long track record of good return and disciplined capital allocation. With exposure to Bunnings, Kmart Group, Officeworks, industrials, and healthcare, Wesfarmers offers diversification within a single holding.
I like having a business in the portfolio that can generate strong cash flows across different economic conditions. Wesfarmers plays that role for me.
$12,000 in CSL Ltd (ASX: CSL)
CSL gives me exposure to global healthcare and long-term structural growth.
After a disappointing period, expectations are lower and sentiment is more balanced. I do not need CSL to deliver spectacular growth to justify owning it. I just need steady execution, margin recovery over time, and continued demand for plasma therapies.
For a medium-sized portfolio, CSL adds global earnings exposure and defensive qualities that complement more cyclical holdings.
$10,000 in TechnologyOne Ltd (ASX: TNE)
TechnologyOne is one of two quality growth stocks in this portfolio.
Its enterprise software is deeply embedded in government, education, and large organisations, where switching costs are high and contracts are long-dated. The shift to SaaS has improved earnings visibility and margins, while international expansion adds a longer growth runway.
Together with its ongoing investment in research and development (20% to 25% of annual revenue), I believe this is an ASX share with a bright future.
$8,000 in Xero Ltd (ASX: XRO)
Xero adds more quality growth exposure to the portfolio.
This ASX share has built a global small business platform with strong recurring revenue and high customer retention. While the share price can be volatile, I think it is worth sticking with Xero because the long-term opportunity is immense if management continues to execute. The company estimates that it has a total addressable market worth $100 billion.
I would not make Xero my largest position, but I am comfortable allocating a meaningful amount to a global SaaS leader that now trades at a more reasonable valuation than in recent years.
$5,000 in the VanEck Morningstar Wide Moat AUD ETF (ASX: MOAT)
Finally, I would round out the portfolio with an ETF.
The VanEck Morningstar Wide Moat AUD ETF gives exposure to fairly valued US-listed stocks with durable competitive advantages. I like this as a way to add diversification and quality without relying on any single stock.
In a $50,000 portfolio, this ETF helps smooth risk and provides exposure to global businesses with pricing power and strong returns on capital. This is never a bad idea.
Why this mix of ASX shares works for me
This portfolio is deliberately simple. It blends defensive qualities, structural growth, global exposure, and diversification without becoming overly complex.
I am not claiming this is the perfect portfolio, or that it will outperform every year. But it reflects how I prefer to invest. Focus on quality, avoid overtrading, and hold businesses I understand and trust.
